More emerging-markets action for GlaxoSmithKline (GSK). The drugmaker has inked a $2.2 billion deal to supply its Synflorix vaccine to Brazil, one of the hottest drug markets in the developing world.
Merck and Wellcome Trust have created the MSD Wellcome Trust Hilleman Laboratories, a not-for-profit R&D venture focused on affordable vaccines to prevent diseases common in low-income countries.
Once public health officials start their mass swine flu vaccination campaigns in October, they'll be bracing for a deluge of complaints about adverse events--most of which won't have anything to do
The long-awaited endorsement of GlaxoSmithKline's HPV vaccine Cervarix is widely expected to pave a short path to formal FDA approval. But Merck isn't sounding all that concerned that its vaccine,
MedImmune, which began clinical trials for its swine flu vaccine last month, says the inhaled vaccine could be ready by the end of September. The AstraZeneca subsidiary is now waiting on the FDA to
A slew of new H1N1 flu treatment news hit over the long weekend, so we're offering a roundup to help you get back up to speed. Roche is supporting research into using its Tamiflu drug in
China's Sinovac Biotech has won swift approval to begin manufacturing the country's first swine flu vaccine. And the regulatory green light will likely be followed up in short order with a second
A human vaccine to guard against the Hendra virus, which recently caused the death of an Australian veterinarian, may be 15 years and one billion dollars away, the renowned scientist Ian Frazer tells
The same HPV vaccines used to guard against cervical cancer in girls and young women could also protect men from a rare penile cancer. But because that cancer is so uncommon, some experts say it just
Faced with alarming projections that swine flu can kill up to 90,000 Americans, U.S. government officials have given vaccine makers a green light to start preparing shipments of a new jab--their